0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

Positron Emission Tomography Finding of a High Striatal D2 Receptor Occupancy in Olanzapine-Treated Patients

Anna-Lena Nordström, MD, PhD; Svante Nyberg, MD, PhD; Hans Olsson, MD; Lars Farde, MD, PhD
Arch Gen Psychiatry. 1998;55(3):283-284. doi:.
Text Size: A A A
Published online

Extract

Clozapine is the prototype atypical antipsychotic drug. The term atypical antipsychotic refers to drugs that do not cause catalepsy in animals, have a minor or no effect on plasma prolactin, do not cause extrapyramidal symptoms in humans, do not cause tardive dyskinesia, are effective in the treatment of negative symptoms, and may be effective in nonresponders to classical neuroleptics. We have previously demonstrated in positron emission tomography (PET) studies that clozapine is atypical also with regard to the degree of striatal D2 dopamine receptor occupancy during clinical treatment. While all classical antipsychotic drugs occupied 70% to 90% of the striatal D2 receptors, the D2 occupancy during clozapine treatment was significantly lower (20%-67%).1 The maximal D2 occupancy during clinical treatment with clozapine at very high plasma concentrations was estimated to be about 60%.2

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

March 1, 1998
Philip Seeman, MD, PhD
Arch Gen Psychiatry. 1998;55(3):284. doi:.
March 1, 1998
Ross J. Baldessarini, MD; Adele C. Viguera, MD
Arch Gen Psychiatry. 1998;55(3):281-282. doi:.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();